A new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, called VIR-5500, is a "masked T-cell engager". This type of immunotherapy ignites our own ...

Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and ...

Early-stage trials of a new drug for advanced prostate cancer have yielded "remarkable" results, according to medical experts. This innovative treatment, an immunotherapy designed to harness the ...

MiraDx, a molecular diagnostics company focused on genetic testing to personalize cancer treatment, today announced the U.S. commercial launch of PROSTOX™ Standard, a new, clinically validated genetic ...

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following ...

Increasing use of blood tests to detect prostate cancer is leading to overworked doctors. NTNU has now created an AI diagnostic tool that can help lighten the burden.

Prostate cancer screening compares favourably to screening for breast cancer in identifying significant cancers, reducing ...

Researchers found men who ejaculated more often had fewer prostate cancer diagnoses, pointing to a possible biological explanation.

Vipul R. Patel, MD, FACS, is a board-certified urologic surgeon, medical director of the Global Robotics Institute at AdventHealth, and medical director of urologic oncology at AdventHealth Cancer ...

For men, a new urine test is improving prostate cancer detection. Men know about the PSA test but there's another test, the "mi-prostate score" or MIPS. It's been available since 2013. It combines PSA ...

Rishi Sunak has urged men to be checked for prostate cancer as part of a new screening drive. The former prime minister has given his backing to an initiative run by the charity P ...